Literature DB >> 31254220

Texture analysis versus conventional MRI prognostic factors in predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced cancer of the uterine cervix.

Maria Ciolina1, Valeria Vinci1, Laura Villani1, Silvia Gigli1, Matteo Saldari1, Pierluigi Benedetti Panici2, Giorgia Perniola2, Andrea Laghi3, Carlo Catalano1, Lucia Manganaro4.   

Abstract

INTRODUCTION: To determine the performance of texture analysis and conventional MRI parameters in predicting tumoral response to neoadjuvant chemotherapy and to assess whether a relationship exists between texture tissue heterogeneity and histological type of uterine cervix cancer. METHOD AND MATERIALS: Twenty-eight patients with local advanced cervical cancer (FIGO IB2-IIIB), underwent MRI before chemotherapy. Texture analysis parameters were quantified on T2-weighted sequences, as well as the maximum diameter expressed in mm. ADC values were obtained on the ADC map. Statistical analysis included unpaired t test and ROC curve.
RESULTS: No statistical correlation was found between conventional parameters and response to NACT. Mean and skewness showed a strong correlation with the histological type: Adenocarcinomas presented higher mean and skewness values (69.8 ± 10.5 and 0.55 ± 0.19) in comparison with squamous cell carcinomas. Using a cutoff value ≥ 29 for mean it was possible to differentiate the two histological types with a sensitivity of 100% and a specificity of 81%. Kurtosis showed a positive correlation with tumor response to NACT resulting higher in responders (v.m. 5.7 ± 1.1) in comparison with non-responders (2.3 ± 0.5). The optimal Kurtosis cutoff value for the identification of non-responders tumors was ≤ 3.7 with a sensitivity of 92% and a specificity of 75%.
CONCLUSION: Texture analysis applied to T2-weighted images of uterine cervical cancer exceeded the role of conventional prognostic factors in predicting tumoral response; moreover, they showed a potential role to differentiate histological tumor types.

Entities:  

Keywords:  Diffusion-weighted imaging; Magnetic resonance imaging; Prognosis; Tumor heterogeneity; Uterine cervical neoplasm

Mesh:

Year:  2019        PMID: 31254220     DOI: 10.1007/s11547-019-01055-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  32 in total

Review 1.  Texture analysis: a review of neurologic MR imaging applications.

Authors:  A Kassner; R E Thornhill
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

2.  Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker.

Authors:  Vicky Goh; Balaji Ganeshan; Paul Nathan; Jaspal K Juttla; Anup Vinayan; Kenneth A Miles
Journal:  Radiology       Date:  2011-08-03       Impact factor: 11.105

3.  Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.

Authors:  Thida Win; Kenneth A Miles; Sam M Janes; Balaji Ganeshan; Manu Shastry; Raymondo Endozo; Marie Meagher; Robert I Shortman; Simon Wan; Irfan Kayani; Peter J Ell; Ashley M Groves
Journal:  Clin Cancer Res       Date:  2013-05-09       Impact factor: 12.531

4.  Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.

Authors:  Jian Z Wang; Nina A Mayr; Dongqing Zhang; Kaile Li; John C Grecula; Joseph F Montebello; Simon S Lo; William T C Yuh
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

5.  Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer.

Authors:  Kanyarat Katanyoo; Sompol Sanguanrungsirikul; Sumonmal Manusirivithaya
Journal:  Gynecol Oncol       Date:  2012-01-28       Impact factor: 5.482

6.  Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival.

Authors:  Balaji Ganeshan; Elleny Panayiotou; Kate Burnand; Sabina Dizdarevic; Ken Miles
Journal:  Eur Radiol       Date:  2011-11-17       Impact factor: 5.315

7.  Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade.

Authors:  Karoline Skogen; Balaji Ganeshan; Catriona Good; Giles Critchley; Ken Miles
Journal:  J Neurooncol       Date:  2012-12-06       Impact factor: 4.130

8.  Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.

Authors:  Francesca Ng; Balaji Ganeshan; Robert Kozarski; Kenneth A Miles; Vicky Goh
Journal:  Radiology       Date:  2012-11-14       Impact factor: 11.105

9.  Quantifying tumour heterogeneity with CT.

Authors:  Balaji Ganeshan; Kenneth A Miles
Journal:  Cancer Imaging       Date:  2013-03-26       Impact factor: 3.909

10.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?

Authors:  Fergus Davnall; Connie S P Yip; Gunnar Ljungqvist; Mariyah Selmi; Francesca Ng; Bal Sanghera; Balaji Ganeshan; Kenneth A Miles; Gary J Cook; Vicky Goh
Journal:  Insights Imaging       Date:  2012-10-24
View more
  7 in total

1.  Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.

Authors:  Lucia Manganaro; Yulia Lakhman; Nishat Bharwani; Benedetta Gui; Silvia Gigli; Valeria Vinci; Stefania Rizzo; Aki Kido; Teresa Margarida Cunha; Evis Sala; Andrea Rockall; Rosemarie Forstner; Stephanie Nougaret
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

2.  Delta radiomics: a systematic review.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Luca Boldrini; Giovanna Vacca; Emma D'Ippolito; Salvatore Annunziata; Alessandra Farchione; Maria Paola Belfiore; Isacco Desideri; Salvatore Cappabianca
Journal:  Radiol Med       Date:  2021-12-04       Impact factor: 3.469

3.  Combination of Radiomics and Machine Learning with Diffusion-Weighted MR Imaging for Clinical Outcome Prognostication in Cervical Cancer.

Authors:  Ankush Jajodia; Ayushi Gupta; Helmut Prosch; Marius Mayerhoefer; Swarupa Mitra; Sunil Pasricha; Anurag Mehta; Sunil Puri; Arvind Chaturvedi
Journal:  Tomography       Date:  2021-08-05

4.  Post-TACE changes in ADC histogram predict overall and transplant-free survival in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up.

Authors:  Mohammadreza Shaghaghi; Mounes Aliyari Ghasabeh; Sanaz Ameli; Maryam Ghadimi; Bita Hazhirkarzar; Roya Rezvani Habibabadi; Pegah Khoshpouri; Ankur Pandey; Pallavi Pandey; Ihab R Kamel
Journal:  Eur Radiol       Date:  2020-09-07       Impact factor: 5.315

Review 5.  Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Authors:  Domenico Albano; Federico Bruno; Andrea Agostini; Salvatore Alessio Angileri; Massimo Benenati; Giulia Bicchierai; Michaela Cellina; Vito Chianca; Diletta Cozzi; Ginevra Danti; Federica De Muzio; Letizia Di Meglio; Francesco Gentili; Giuliana Giacobbe; Giulia Grazzini; Irene Grazzini; Pasquale Guerriero; Carmelo Messina; Giuseppe Micci; Pierpaolo Palumbo; Maria Paola Rocco; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2021-12-24       Impact factor: 2.374

Review 6.  Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe.

Authors:  Domenico Albano; Massimo Benenati; Antonio Bruno; Federico Bruno; Marco Calandri; Damiano Caruso; Diletta Cozzi; Riccardo De Robertis; Francesco Gentili; Irene Grazzini; Giuseppe Micci; Anna Palmisano; Carlotta Pessina; Paola Scalise; Federica Vernuccio; Antonio Barile; Vittorio Miele; Roberto Grassi; Carmelo Messina
Journal:  Insights Imaging       Date:  2021-06-10

Review 7.  Radiomics in cervical and endometrial cancer.

Authors:  Lucia Manganaro; Gabriele Maria Nicolino; Miriam Dolciami; Federica Martorana; Anastasios Stathis; Ilaria Colombo; Stefania Rizzo
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.